Different Volumetric Measurement Methods for Pituitary Adenomas and Their Crucial Clinical Significance
Open Access
- 18 January 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 40792
Abstract
Confirming the status of residual tumors is crucial. In stationary or spontaneous regression cases, early treatments are inappropriate. The long-used geometric calculation formula is 1/2 (length × width × height). However, it yields only rough estimates and is particularly unreliable for irregularly shaped masses. In our study, we attempted to propose a more accurate method. Between 2004 and 2014, 94 patients with pituitary tumors were enrolled in this retrospective study. All patients underwent transsphenoidal surgery and received magnetic resonance imaging (MRI). The pre- and postoperative volumes calculated using the traditional formula were termed A1 and A2, and those calculated using the proposed method were termed O1 and O2, respectively. Wilcoxon signed rank test revealed no significant difference between the A1 and O1 groups (P = 0.1810) but a significant difference between the A2 and O2 groups (P < 0.0001). Significant differences were present in the extent of resection (P < 0.0001), high-grade cavernous sinus invasion (P = 0.0312), and irregular shape (P = 0.0116). Volume is crucial in evaluating tumor status and determining treatment. Therefore, a more scientific method is especially useful when lesions are irregularly shaped or when treatment is determined exclusively based on the tumor volume.Keywords
This publication has 57 references indexed in Scilit:
- Semiautomated Volumetric Measurement on Postcontrast MR Imaging for Analysis of Recurrent and Residual Disease in Glioblastoma MultiformeAmerican Journal of Neuroradiology, 2013
- Pituitary Adenoma Volumetry with 3D SlicerPLOS ONE, 2012
- Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysisPituitary, 2011
- Volumetric Measurement for Comparison of the Accuracy between Intraoperative CT and Postoperative MR Imaging in Pituitary Adenoma SurgeryAmerican Journal of Neuroradiology, 2011
- Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patientsEuropean Journal of Endocrinology, 2010
- Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's SyndromeNeurosurgical Focus, 2007
- The natural course of non-functioning pituitary macroadenomasEuropean Journal of Endocrinology, 2007
- Surgical management of adrenocorticotropic hormone—secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndromeJournal of Neurosurgery, 2005
- Stereotactic conformal radiotherapy in patients with growth hormone–secreting pituitary adenomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Endocrinological Outcome Following First Time Transsphenoidal Surgery for GH-, ACTH-, and PRL-Secreting Pituitary AdenomasActa Neurochirurgica, 2002